These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33731294)

  • 1. Benzimidazole based hybrids against complex diseases: A catalogue of the SAR profile.
    Choudhary S; Arora M; Verma H; Kumar M; Silakari O
    Eur J Pharmacol; 2021 May; 899():174027. PubMed ID: 33731294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Approach to Potential Anticancer Benzimidazole Derivatives: A Review.
    Kumar R; Singh C; Mazumder A; Salahuddin ; Abdullah MM; Kumar V; Giri PP
    Mini Rev Med Chem; 2022; 22(9):1289-1304. PubMed ID: 34598663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure activity relationship (SAR) study of benzimidazole scaffold for different biological activities: A mini-review.
    Yadav G; Ganguly S
    Eur J Med Chem; 2015 Jun; 97():419-43. PubMed ID: 25479684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel research strategies of benzimidazole derivatives: a review.
    Barot KP; Nikolova S; Ivanov I; Ghate MD
    Mini Rev Med Chem; 2013 Aug; 13(10):1421-47. PubMed ID: 23544603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic journey of benzimidazoles: a review.
    Bansal Y; Silakari O
    Bioorg Med Chem; 2012 Nov; 20(21):6208-36. PubMed ID: 23031649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzimidazole as a Privileged Scaffold in Drug Design and Discovery.
    Kumar R; Marianesan AB; Pathak S
    Curr Top Med Chem; 2024; 24(17):1504-1528. PubMed ID: 38818908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure-Activity Relationship.
    Shrivastava N; Naim MJ; Alam MJ; Nawaz F; Ahmed S; Alam O
    Arch Pharm (Weinheim); 2017 Jun; 350(6):. PubMed ID: 28544162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coumarin-benzimidazole hybrids: A review of developments in medicinal chemistry.
    G AC; Gondru R; Li Y; Banothu J
    Eur J Med Chem; 2022 Jan; 227():113921. PubMed ID: 34715585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Critical Review on Therapeutic Potential of Benzimidazole Derivatives: A Privileged Scaffold.
    Natarajan R; Kumar P; Subramani A; Siraperuman A; Angamuthu P; Bhandare RR; Shaik AB
    Med Chem; 2024; 20(3):311-351. PubMed ID: 37946342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Activities of 1-H-Benzimidazole-based Molecules.
    Ates-Alagoz Z
    Curr Top Med Chem; 2016; 16(26):2953-2962. PubMed ID: 27150377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzimidazole-Oxadiazole Hybrids-Development in Medicinal Chemistry: An Overview.
    Bhat RM; Hegde V; Budagumpi S; Adimule V; Keri RS
    Chem Biol Drug Des; 2024 Aug; 104(2):e14609. PubMed ID: 39155152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Applications of Benzimidazole as a Privileged Scaffold in Drug Discovery.
    Guo Y; Hou X; Fang H
    Mini Rev Med Chem; 2021; 21(11):1367-1379. PubMed ID: 32753010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Potential of Benzimidazole Derived Molecules.
    Bansal Y; Kaur M; Bansal G
    Mini Rev Med Chem; 2019; 19(8):624-646. PubMed ID: 29090668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlocking the Pharmacological Potential of Benzimidazole Derivatives: A Pathway to Drug Development.
    Monga J; Ghosh NS; Rani I; Singh R; Deswal G; Dhingra AK; Grewal AS
    Curr Top Med Chem; 2024; 24(5):437-485. PubMed ID: 38311918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
    Maghraby MT; Abou-Ghadir OMF; Abdel-Moty SG; Ali AY; Salem OIA
    Bioorg Med Chem; 2020 Apr; 28(7):115403. PubMed ID: 32127262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Development of Benzimidazole-Containing Antibacterial Agents.
    Song D; Ma S
    ChemMedChem; 2016 Apr; 11(7):646-59. PubMed ID: 26970352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionalized Benzimidazole Scaffolds: Privileged Heterocycle for Drug Design in Therapeutic Medicine.
    Ajani OO; Aderohunmu DV; Ikpo CO; Adedapo AE; Olanrewaju IO
    Arch Pharm (Weinheim); 2016 Jul; 349(7):475-506. PubMed ID: 27213292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzimidazoles: an ideal privileged drug scaffold for the design of multitargeted anti-inflammatory ligands.
    Kaur G; Kaur M; Silakari O
    Mini Rev Med Chem; 2014; 14(9):747-67. PubMed ID: 25138088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole and related heterocycles.
    Burgeson JR; Moore AL; Gharaibeh DN; Larson RA; Cerruti NR; Amberg SM; Hruby DE; Dai D
    Bioorg Med Chem Lett; 2013 Feb; 23(3):750-6. PubMed ID: 23265900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives of Benzimidazole Derivatives as Anticancer Agents in the New Era.
    Yadav S; Narasimhan B; Kaur H
    Anticancer Agents Med Chem; 2016; 16(11):1403-1425. PubMed ID: 26526461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.